Skip to main content

Table 1 Patient demographic, disease, and treatment characteristics

From: Indirect costs associated with out-of-country referral for proton therapy: a survey of adult and pediatric patients in Alberta, Canada

Characteristic

All Patients (n = 17)

Adult Patients (n = 8)

Pediatric Patients (n = 9)

Median age at treatment, years (range)

14 (1–68)

47 (25–68)

9 (1–14)

Gender

 Female

13 (76%)

8 (100%)

5 (56%)

 Male

4 (24%)

0 (0%)

4 (44%)

Diagnosis

 Chordoma

1 (6%)

1 (13%)

0 (0%)

 Chondrosarcoma

6 (35%)

6 (75%)

0 (0%)

 Craniopharyngioma

3 (18%)

1 (13%)

0 (0%)

 Osteoblastoma

1 (6%)

0 (0%)

3 (33%)

 Medulloblastoma

2 (12%)

0 (0%)

2 (22%)

 Nongerminomatous germ cell tumor

2 (12%)

0 (0%)

2 (22%)

 Ependymoma

1 (6%)

0 (0%)

1 (11%)

 Rhabdomyosarcoma

1 (6%)

0 (0%)

1 (11%)

Referral location

 Jacksonville, FL

8 (47%)

0 (0%)

8 (89%)

 Boston, MA

5 (29%)

5 (63%)

0 (0%)

 Loma Linda, CA

3 (18%)

3 (38%)

0 (0%)

 Memphis, TN

1 (6%)

0 (0%)

1 (11%)

Treatment Year

 2009–2013

5 (29%)

4 (50%)

1 (11%)

 2014–2018

12 (71%)

4 (50%)

8 (89%)

Median number of fractions (range)

33 (20–40)

37 (35–40)

30 (20–33)

Median length of stay in US, days (range)

61 (44–81)

65 (52–81)

56 (44–62)

  1. Percentages in each category may not total 100% due to rounding